In the battle of the giants it is Israel’s Teva that is the heavyweight, and the American company, the lightweight.
Robert Coury, Chairman and Chief Executive Officer of Mylan: Fighting fiercely against a takeover by Teva(photo credit: CHIP EAST / REUTERS)BySHLOMO MAITALRead More